Art
J-GLOBAL ID：200902243475768800
Reference number：05A0458257
SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C
慢性C型肝炎患者におけるインターフェロンに基づく治療効果を予想するマーカーとしてのオステオポンチン遺伝子のプロモーター領域におけるSNPs
-
Publisher site
Copy service
{{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=05A0458257©=1") }}
-
Access JDreamⅢ for advanced search and analysis.
{{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=05A0458257&from=J-GLOBAL&jstjournalNo=Z0748A") }}
Author (9)：
,
,
,
,
,
,
,
,
Material：
Volume：
40
Issue：
4
Page：
381-388
Publication year：
Apr. 2005
JST Material Number：
Z0748A
ISSN：
0944-1174
Document type：
Article
Article type：
原著論文
Country of issue：
Germany, Federal Republic of (DEU)
Language：
ENGLISH (EN)
Thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
JST classification (3)：
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for digestive system diseases
, Treatment for infectious diseases,parasitic diseases.
, Structure and chemistry of genes
Substance index (1)：
Substance index
Chemical Substance indexed to the Article.
Reference (30)：
-
CERNY, A. Pathogenesis of chronic hepatitis C : immunological features of hepatic injury and viral persistence. Hepatology. 1999, 30, 595-601
-
FRIEDMAN, SL. Seminars in medicine of the Beth Israel Hospital, Boston, The cellular basis of hepatic fibrosis : mechanisms and treatment strategies. N Engl J Med. 1993, 328, 1828-1835
-
YOSHIDA, H. Interferon therapy reduces the risk for hepatocellular carcinoma : National surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med. 1999, 131, 174-181
-
ARASE, Y. Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C. J Gastroenterol. 2000, 35, 221-225
-
SHIRATORI, Y. Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group. Gastroenterology. 1997, 113, 558-566
ｍore...
Terms in the title (10)：
Terms in the title
Keywords automatically extracted from the title.
,
,
,
,
,
,
,
,
,
Return to Previous Page
